Detalles de la búsqueda
1.
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors.
Med
; 4(2): 113-129.e7, 2023 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36693381
2.
Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients.
J Cancer Res Clin Oncol
; 148(3): 647-656, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34874490
3.
Autoreactive napsin A-specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade.
Sci Immunol
; 7(75): eabn9644, 2022 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36054337
4.
Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival.
Oncoimmunology
; 10(1): 2006893, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34858733
5.
Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment.
J Immunother
; 42(3): 89-93, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30768543
6.
Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients.
J Immunother Cancer
; 7(1): 50, 2019 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30786924
7.
Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy.
Science
; 366(6467): 881-886, 2019 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31727837
8.
Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung Cancer.
JAMA Oncol
; 5(7): 1043-1047, 2019 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31021392
9.
Risk score for non-small cell lung cancer patients starting checkpoint inhibitor treatment.
Cancer Manag Res
; 10: 5537-5544, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30519101
Resultados
1 -
9
de 9
1
Próxima >
>>